Branch retinal artery occlusion

Branch retinal artery occlusion (BRAO) is a rare retinal vascular disorder in which one of the branches of the central retinal artery is obstructed.[1]

Branch retinal artery occlusion
Central retinal artery(at right)
SpecialtyOphthalmology

Presentation

Abrupt painless loss of vision in the visual field corresponding to territory of the obstructed artery is the typical history of presentation. Patients can typically define the time and extent of visual loss precisely.

Retinal whitening that corresponds to the area of ischemia is the most notable finding. In chronic phase the retinal whitening disappears.

Risk factors

Risk factors include:

Diagnosis

Ancillary testing is not usually necessary to make the diagnosis. Fluorescein angiography reveals an abrupt diminution in dye at the site of the obstruction. Visual field testing can confirm the extent of visual loss.

Treatment

No proved treatment exists for branch retinal artery occlusion. In the rare patient who has branch retinal artery obstruction accompanied by a systemic disorder, systemic anti-coagulation may prevent further events.[1]

Epidemiology

The mean age of affected patients is 60 years. The right eye is affected more commonly than the left eye which probably reflects the greater possibility of cardiac or aortic emboli traveling to the right carotid artery. Most of the cases are due to emboli to the retinal circulation. Three main types of retinal emboli have been identified: Cholesterol, calcific, and fibrin-platelet.

gollark: Octahedral/bee-isomorphic?
gollark: Memory leak good, as they say.
gollark: No, this is flawless and without flaw.
gollark: Codegen, I mean.
gollark: To make it easier, just assign each variable its own unique location in memory and continuously read/write from those to registers.

See also

References
  1. Myron Yanoff; Jay S. Duker (2009). Ophthalmology (3rd ed.). Mosby Elsevier. pp. 592–594. ISBN 9780323043328.
Classification
External resources
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.